Found insideLook no further than the new 5th edition of the best-selling Manual for Pharmacy Technicians to master the practical skills and gain the foundational knowledge all technicians need to be successful. Found inside – Page 72... then guides the pharmacist with a list through Rx-validation and dispensing, and offers drug grids in order to improve appropriate interventions. endstream endobj startxref b. is an unapproved drug product that appears on the drug shortage list in effect under section 506E of the FD&C Act, and the repackaged drug product is distributed during any period in which it . Found inside – Page 113or } ( iii ) Changes that may affect drug substance or drug product ... ( B ) If applicable , any change to a the Medication Guide required under part 3208 ... Allergy Interactions and Drug-Drug Interactions from pending medications are displayed below the Patient Information section: There is also a highlighted bar across the Active Medication List noting the number of interactions within existing/active medications. Mubarak Patel April 16, 2021. Medication Aide Course Training Requirements and Directions for Use vii Student Manual ix Course Objectives x Course Schedule xiii Definitions xv Section A Prerequisite Skills Review and Validation A-1 Teaching Guide A-2 Course Content A-3 Section B Medication Aide in Adult Care Homes B-1 Teaching Guide B-2 Course Content B-3 Found inside – Page 572... Monster, This Boy's Life, Schindler's List, Saving Private Ryan, ... as our goal is to prioritize the internal validity of treatment effects. Results: the expert panel agreed a final list of 114 criteria after two Delphi validation rounds, i.e. h��V�oe��]w����nc[eZ\�}�40pc�2��]W�Fhi\u N�0��t��\�d�[ !8Ɨ��Մ��"�HXL�aZg\�������vL� ���}���. 9427 0 obj <> endobj Medication Administration Record (MAR) Guidelines, with lessons The State of Florida and APDCares.org (APD) do not control or guarantee the accuracy, relevance, timeliness or completeness of information contained on a linked website. KANSAS CERTIFIED MEDICATION AIDE CURRICULUM Certified Medication Aide Curriculum Revision Committee: Amanda Baloch, CMA Janette Chase, RN, RAC-CT JoZana Smith, RN Kim Halbert, RN, BS, LACHA Mary Robinson, CMA Roxy Richard, RN Susan Fout, RN, Kansas Department on Aging Tamera Sanchez, RN Vera VanBruggen, RN, BA, Long-Term Care Director, Licensure, Certification, and Evaluation Commission, See INDICATIONS for specific uses. Cleaning Validation Protocol CONTENTS S. No. Found inside – Page 73... patient) 4.2 Patient package insert and medication guide requirements (eg, ... and expiration dates 7.2 Formulary or approved/preferred product list 7.3 ... Found inside – Page 113... any change to a used and studies performed to assess Medication Guide ... validation protocols be reported in an annual report under and a list of ... The purpose of this competency assessment tool is to evaluate the employee's knowledge, skills and ability for medication administration. All criteria identified on the assessment is taught to the employee during new employee orientation, periodically or Overview of FDA Requirements for OTC Drugs 80 STOPP criteria and 34 START criteria. In 1996 the Institute of Medicine launched the Quality Chasm Series, a series of reports focused on assessing and improving the nation's quality of health care. Preventing Medication Errors is the newest volume in the series. The delegating nurse utilizes the tool at designated intervals: time of hire, three months, six months and annually thereafter. • The drug or other substance has a currently accepted medical use in treatment in the United States. 0 Cleaning of equipment was first published in the Code of Feral Regulations (CFR) as 21CFR211.67 Equipment Cleaning and Maintenance in 1978. Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). Found inside – Page 90STOPP Criteria List (Screening Tool of Older Person's Prescriptions) 5. psychosocial interventions and medication 6. validation e. ISMP SAFE PRACTICE GUIDELINES FOR ADULT IV PUSH MEDICATIONS ISMP 2015 Introduction Intravenous (IV) therapy is considered an essential component of current healthcare delivery, with over 90% of hospitalized patients receiving some form of infusion therapy. The emphasis in this guide is on WHO requirements for validation. Opening the consultation. for drug products or particle size determination for drug substance, these have not been addressed in the initial text on validation of analytical procedures. Quality Assurance and Competency Tools. If your company has 1-50 employees, your prescription drug benefits through BCBSIL are based on a Drug List, which is a list of drugs considered to be safe and effective. Found inside – Page 314A Guide for Health Care Facilities Henri Richard Manasse, ... The prioritized list is then presented to the entire project team for validation. The information on this page is current as of April 1 2020. A typical approach to validation based on system complexity and risk is given as a summary below. Section 1: Basic Medication Administration Information and Medical Terminology . A. The validation must be conducted by an RN - 10A NCAC 13O .0202 (a). Cleaning Validation is a critical component of an effective GMP Compliance program at any regulated drug manufacturing facility. Guidance for Industry. The N.C. 1179 0 obj <>stream Drugs. lick on the "+" icon to expand the list to show the different interactions. Medication Aide Skills Assessment Study Guide Skills Assessments are designed to validate that an individual understands and can safely and accurately perform the skills required to function as a medication aide. Topic Page No. At a minimum, issuers should refer to the Data Integrity Tool (DIT . SPL Implementation Guide with Validation Procedures . The validation procedures are performed along with the system suitability. However, if you plan to market OTC drugs with active ingredients that are not part of the OTC monograph, you should obtain FDA approval through the new drug approval process. Sec. endstream endobj startxref Found inside – Page 111( B ) If applicable , any change to a Medication Guide required under part 208 ... relevant validation protocols and a list of relevant standard operating ... there are two Types of Analytical Procedures first is Specifications and standard test method in Pharmacopoeias or Pharmacopoeial methods and second one Non . It is not the intention to be prescriptive in specific validation requirements. Please call the medical case manager in any APD regional office to obtain a list of approved . medications, the long-term care/skilled nursing facility employer must conduct a clinical skills validation for those medication tasks to be performed in the facility. CMS also reserves the right to request off-cycle revalidations. Click on drug name to view Medication Guide in PDF format. Found inside – Page 494Payment Validation for Medicare Part C and Part D Programs (continued) the process of verifying ... The MTM provides a list of a beneficiary's medications, ... The five steps are -. The Guide presents a review of the types and extent of validations required by GMP, Structured Product Labeling (SPL) Implementation Guide with Validation Procedures . and validation of skills required for medication administration. It is observed that a 20% increase in temperature can reduce the efficiency of drug up to 25% those are stored at 2-8°C. This represents an overall 31% increase in STOPP/START criteria compared with version 1. (a) General. Match common medical abbreviations with their meaning : B. List/Describe common dosage forms of 12 Siliconization of Parenteral Drug Packaging Components 1988 43217 13 Fundamentals of an Environmental Monitoring Program Revised 2014 (Published 1990) 43513 14 Validation of Column-Based Chromatography Processes for the Purification of Proteins Revised 2008 (Published 1992) 43220 Found inside – Page 94Size of Beads in Drug Products Labeled for Sprinkle , 3144 Target Animal ... Validation Methods and Labeling , 24494 Draft Guidance for Industry and FDA ... A typical approach to validation based on system complexity and risk is given as a summary below. This document serves as general guidance only, and the principles may be considered useful in its application in the . Lidocaine HCl Injection, USP is a sterile, nonpyrogenic, aqueous solution that contains a local anesthetic agent and is administered parenterally by injection. 1150 0 obj <> endobj 12 Siliconization of Parenteral Drug Packaging Components 1988 43217 13 Fundamentals of an Environmental Monitoring Program Revised 2014 (Published 1990) 43513 14 Validation of Column-Based Chromatography Processes for the Purification of Proteins Revised 2008 (Published 1992) 43220 Note: These documents are reference material for investigators and other FDA personnel . Found inside – Page 336When a hospital undergoes a validation survey by a state agency to ensure ... support safe medication management.7 See Table 17-2 for the list of medication ... Competency Validation by a RN or RPhprior to administration of medications (Non‐transferable) Within 90 days of competency validation Pass the written State medication exam for unlicensed staff in adult care homes Effective 10/01/2013 Verification of employment as a medication aide in an ACH within Medication Administration Skills Validation Form & Instructions Form - 4605 (PDF, 164 KB) Guidelines for the Medication Administration Skills Validation Form - 4698; Medication Aide Employment Verification - 4664 (PDF, 164 KB) Medication Release Form for Resident Leave of Absence - 4693 (PDF, 34 KB) Part 2. Page 2 of 37 This guidance document "Validation of Production Processes for Vaccines for WHO Prequalification - Compliance Expectations" is one of a series developed by WHO/EMP/VQR team upon request from the manufacturers' members of the Developing Countries Vaccine Manufacturers Network (DCVMN), with funds from USAID. Found inside – Page 345When journalists write articles about socalled wonder drugs , they must be careful to ask the right questions . Are studies purporting to validate drugs ... %PDF-1.5 %���� The new "2010 Red Book" contains extensive updates and additions and provides the latest pricing and product information on more than 100,000 prescription and OTC items. DHSR/AC 4698 (Revised 10/05 , 10/10,02/11, 06/16, 05/21) NCDHHS . This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see, U.S. Department of Health and Human Services, Instructions for Downloading Viewers and Players, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf#page=77, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021436s043,021713s034,021729s026,021866s028lbl.pdf#page=84, FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202971s013lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207202s002s004lbl.pdf#page=48, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207202s003lbl.pdf#page=44, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761118s000lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021951s013lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022510s018lbl.pdf#page=29, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018662s061MedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020973s041lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204736s012lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125276s129,125472s042lbl.pdf#page=46, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125276s131lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125472s044lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020747s053lbl.pdf#page=43, http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020835s048lbl.pdf#page=38, http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020835s052lbl.pdf#page=38, http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021823s011lbl.pdf#page=27, Metformin Hydrochloride; Pioglitazone Hydrochloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021842s022lbl.pdf#page=41, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022024s014lbl.pdf#page=41, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022549s006lbl.pdf#page=26, Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM467750.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021303s034lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022526s009lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204819s015lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212038s002lbl.pdf#page=25, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208471Orig1s000lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208471s004lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204325s000lbl.pdf#page=26, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL, http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204326s002mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022472s011lbl.pdf#page=12, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019908s046lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021774s027lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761024s004lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022250s018lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019906s043lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s045lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf#page=25, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018766s015MedGuide.pdf, Acetaminophen; Benzhydrocodone Hydrochloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208653s007lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022108s014lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022108s020lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022108s021lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205831s005lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205831s006lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022416s011lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103951s5377lbl.pdf#page=25, http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022383s000MedG.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207356s004lbl.pdf#page=15, SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207533s004lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207533s017,209830s005lbl.pdf#page=72, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm085919.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020406s033lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020607s036lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208603s005lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125326s070lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204096s009lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022560s011lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017794s048lbl.pdf#page=13, http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202992s012s014lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202992s013s015lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208082s004lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208082s007lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208082s009lbl.pdf#page=25, Metformin Hydrochloride; Rosiglitazone Maleate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021410s040lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021700s021lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021071s052lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022219s014lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021085s065,021277s061lbl.pdf#page=33, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM311346.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103628s5264lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761086s000lbl.pdf#page=48, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022504s016lbl.pdf#page=15, Dexmethylphenidate Hydrochloride; Serdexmethylphenidate Chloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212994s000lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761049s005lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761049s009lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761078s000lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s006,208611s005lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208610s007,208611s006lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207932s015lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204569s005lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204569Orig1s007lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204569s006lbl.pdf#page23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204569s008lbl.pdf#page=23, http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125370s073,761043s013lbl.pdf#page=42, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125370s068,761043s008lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125370s073,761043s013lbl.pdf#page=42, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103471s5193lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208383s000lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202344s008lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761158s000lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125557s012lbl.pdf#page=33, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf#page=19, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021858s022lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211939s000lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103000s5320lbl.pdf#page=51, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210496s003lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022433s032lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204516s005lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204516s011lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205836s009,205837s007,205838s006lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021912s013lbl.pdf#page=22, Buprenorphine Hydrochloride; Naloxone Hydrochloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205637s021lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021306s037lbl.pdf#page=43, FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022200s026lbl.pdf#page=31, SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209210s002s003s004s005s006s007s008lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209210s011lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209210s014lbl.pdf#page=33, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191084.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021773s044lbl.pdf#page=32, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM169077.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022165s013s014lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103948s5183lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022405s017lbl.pdf#page=20, http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020712s032s035mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208042s004lbl.pdf#page=30, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM135935.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020142s029lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020998s056lbl.pdf#page=22, http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020998s033,021156s003MedG.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020822s052lbl.pdf#page=26, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088568.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050722s040,050723s041,050758s037,050759s045lbl.pdf#page=38, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229201.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494Orig1s000lbl.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021928s048lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212266s000lbl.pdf#page=14, Amitriptyline Hydrochloride; Chlordiazepoxide, http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/071297Orig1s026MG.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125160s283lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125160s237lbl.pdf#page=40, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125160s289lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125160s293lbl.pdf#page=41, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019537s093,020780s049lbl.pdf#page=40, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM246794.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019847s059lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019847s060lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019847s061lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019847s062lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019857s066lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019857s070lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019857s072lbl.pdf#page=33, Ciprofloxacin; Ciprofloxacin Hydrochloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021473s043lbl.pdf#page=30, Citric Acid; Magnesium Oxide; Sodium Picosulfate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209589s006lbledt.pdf#page=14, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088573.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022402s014lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202245s005lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202245s006s007lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202245s008lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202245s009lbl.pdf#page=29, http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022352s022lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022352s026lbl.pdf#page=25, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM176363.pdf, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088574.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021121s044lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210045s009lbl.pdf#page=10, Bupropion Hydrochloride; Naltrexone Hydrochloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200063s020lbl.pdf#page=40, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022370s023lbl.pdf#page=35, http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021511s029lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206143s008,209964s002lblrpl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209964lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125504s031lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125504s035lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125504s043lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205489s007lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/009218s118lbl.pdf#page=30, http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020725s016lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020725s026lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761058s003lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021427s056lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022522s009lbl.pdf#page=17, http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016721s077lbl.pdf, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187067.pdf, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187068.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210656s002s004lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018841s033lbl.pdf#page=25, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088580.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020776s008lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020776s010lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021514s032lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212028s000lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/005010s059lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018081s070,018082s053lbl.pdf#page=41, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018081Orig1s068%20018082Orig1s051lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018723s064lbl.pdf#page=48, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019680s051lbl.pdf#page=42, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021168s042lbl.pdf#page=48, Emtricitabine; Tenofovir Alafenamide Fumarate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208215s011lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208215s019lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/005378s035lbl.pdf#page=12, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204150s018lbl.pdf#page=32, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM372058.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205583s010lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018207s033lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017078s052lbl.pdf#page=11, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022287s034lbl.pdf#page=23, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088583.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/084349s085lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/084427s039s041lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/008762s060s061lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019891s029,019892s037lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/006134s049lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/006134s050lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018708s027lbl.pdf#page=9, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204781s009lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204781s012lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212516s002lbl.pdf#page=46, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016295s051lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021925s017lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022519s013lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019813s081lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209203s000lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208147s003lbl.pdf#page=15, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/ 208147s005lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125274s115lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125274Orig1s118lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021997s011lbl.pdf#page=23, http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020151s031s055s058s060lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020699s114lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022307s018lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204417s000lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204417s004lbl.pdf#page=25, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088587.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202155s032lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020193s015lbl.pdf#page=11, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212157s000lbl.pdf#page=24, Morphine Sulfate; Naltrexone Hydrochloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022321s028s029lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022321s030lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021336s014lbl.pdf#page=34, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088589.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/ 103795s5569lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103795s5563s5564lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103795s5574s5577lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761139s011lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125476s038s039lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206406s007lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022090s015,201277s015lbl.pdf#page=51, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210365s008lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103234s5363s5366lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021652s023lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021652s028lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021710s11s012lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761042s012lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203388s011lbl.pdf#page=12, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203388s012lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203388s014lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203388s016lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202342s006lbl.pdf#page=29, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM359235.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209905s000lbl.pdf#page=15, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf#page=19, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088593.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021217s025lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021882s033lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125290s070lbl.pdf#page=16, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM135933.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021158s026lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202293s018lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202293s020lbl.pdf#page=47, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202293s021lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202293s024lbl.pdf#page=50, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM436377.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018147s050lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213150s000lbl.pdf#page=15, http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/077312MedGuide.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/078907MedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021947s034lbl.pdf#page=42, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021825s008lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208030s005lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212266s000lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212269s001lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204168s007lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212102s000lbl.pdf#page=23, Acetaminophen; Butalbital; Caffeine; Codeine Phosphate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020232s044lbl.pdf#page=41, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020232s045lbl.pdf#page=42, Aspirin; Butalbital; Caffeine; Codeine Phosphate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019429s044s045lbl.pdf#page=41, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208078s000lbl.pdf#page=11, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021234s019lbl.pdf#page=24, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022424s002lbl.pdf#page=26, http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019735s061MedG.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202133s012lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021278s029lbl.pdf#page=15, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021802s039lbl.pdf#page=18, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088602.pdf, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088603.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022497s004lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022497s008lbl.pdf#page=33, http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021318Orig1s054lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021463s025lbl.pdf#page=21, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM241519.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020560s068,021575s024lbl.pdf#page=24, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM241521.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021762s022lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021468s020,204734s001lbl.pdf#page=12, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021468s021,204734s003lbl.pdf#page=12, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021468s023,204734s005lbl.pdf#page=12, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202834s012,208277s001lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202834s014,208277s002lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf#page=24, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229203.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201277s018lbl.pdf#page=22, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM333533.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203341s018lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022527s029s030lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209388s001lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210942s000lbl.pdf#page=11, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210942Orig1s001lbl.pdf#page=12, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206073s027s030lbl.pdf#page=32, Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Sulfate Anhydrous, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019011s033lbl.pdf#page=9, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM245196.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/008372s068lbl.pdf#page=18, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM231714.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761059s000lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017892s055lbl.pdf#page=20, Bisacodyl; Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride, FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM220644.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761083s011lbl.pdf#page=21, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM250398.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022399s010lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761154s000lbl.pdf#page=41, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125057s403lbl.pdf#page=53, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125057s409lbl.pdf#page=56, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125057s417lbl.pdf#page=60, Homatropine METhylbromide; Hydrocodone Bitartrate, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/005213s039lbl.pdf#page=27, http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204278Orig1s000MG.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761071lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761071s001lbl.pdf#page=6, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206627s012lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211801s000lbl.pdf#page=13, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203469s022lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203469s032lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203469s033lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203469s034lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209606s004lbl.pdf#page=17, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM352352.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125319s088lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125319s097lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125319s100lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf#page=10, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761069s028lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/087846s028,087844s027,087845s027lbl.pdf#page=3, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM256383.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016059s101lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017814s044lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018332s042lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018185s058lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018829s023lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018851s028lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018858s047lbl.pdf#page=26, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM497384.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125544s018lbl.pdf#page=61, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022328s008lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103132s5196lbl.pdf#page=40, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229206.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020628s046,021785s022lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020628s047,021785s023lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021785s024lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021785s025lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204353s033,205879s011lbl.pdf#page=59, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204353s039,205879s017lbl.pdf#page=58, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204042s032lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204042s034lbl.pdf#page=48, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204042s036lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761072s006lbl.pdf#page=43, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206910s012lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206910s015lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207968s007lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207968s009lbl.pdf#page=31, Metformin Hydrochloride; Sitagliptin Phosphate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022044s048lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202270s018lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202270Orig1s022lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021995s042lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021995s045lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021995s046lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021995s047lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204629s026lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761174s000lbl.pdf#page=20, http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761223s000lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201281s025lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201281s024lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208026s013lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208026s012lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761085s000lbl.pdf#page=9, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209311s008lbl.pdf#page=19, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM275945.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203858s017lbl.pdf#page=32, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204441lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020616s065lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125277s081lbl.pdf#page=13, http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021226s048lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021226s045lbl.pdf#page=50, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021226s047lbl.pdf#page=53, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021226s049lbl.pdf#page=53, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021251s055,021906s050lbl.pdf#page=51, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021251s058,021906s053lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021251s059,021906s054lbl.pdf#page=53, Alogliptin Benzoate; METformin Hydrochloride, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337729.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203414s007lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021035s102,021505s042lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021035s104,021505s044lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022285s029lbl.pdf#page=26, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088615.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021144s019lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761037s001lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125514s102lbl.pdf#page=116, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204683s005lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204683s006lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017533s061lbl.pdf#page=22, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017533s058lbl.pdf#page=20, Metformin Hydrochloride; Saxagliptin Hydrochloride, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM280360.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/200678s018lbl.pdf#page=47, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200678s024lbl.pdf#page=47, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202107s007lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf#page=20, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM227568.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125293s092lbl.pdf#page=14, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337730.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LacosamideTabletsCVMedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE TABLETSMedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LACOSAMIDE ORAL SOLUTIONMed Guide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf#page=65, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020241s056,020764s049,022251s020lbl.pdf#page=64, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022115s029lbl.pdf#page=51, https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022509lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf#page=11, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020539s029,022071s013lbl.pdf#page=10, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205626s000lbl.pdf#page=50, https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019591s026s028lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200603s035lbl.pdf#page=62, http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022569s024lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022569s027lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022569s030lbl.pdf#page=35, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088617.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022081s041lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020634s069lbl.pdf#page=51, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020634s070lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020634s071lbl.pdf#page=53, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020634s073lbl.pdf#page=54, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088619.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/ 021365s038,021323s053lbl.pdf#page=21, Chlordiazepoxide Hydrochloride; Clidinium Bromide, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/012750s067lbl.pdf#page=11, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/012249s049lbl.pdf#page=8, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761097s007lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206976s000lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206976s007lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016949s041lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneLotionMedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/LindaneShampooMedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202811s018lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017812s031,018421s031,018558s026lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017812s033,018421s032,018558s027lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017812s034,018421s033,018558s028lbl.pdf#page=20, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088624.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761104s000lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761121s001lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761104s003lbl.pdf#page=18, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM134691.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021476Orig1s038rplLBL.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213716s000lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019010s038lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020263s042lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020263s046lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020263s044s047lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021519s018lbl.pdf#page=31, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM249169.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022033s011lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213378s000lbl.pdf#page=40, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206162s008lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206162s011lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208558s000lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208558s019s020lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021446s032,022488s011lbl.pdf#page=50, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021446s035,022488s013lbl.pdf#page=54, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021446s036,022488s014lbl.pdf#page=56, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209501s000lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019596s064s065lbl.pdf#page=12, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021037s037s038lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011961s045lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022561s000lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209884s000lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209884s003lbl.pdf#page=22, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020632s034s035MedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021259s032lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021419s010lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021475s011lbl.pdf#page=13, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM244086.pdf, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM187064.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022246s009lbl.pdf#page=18, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088643.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020687s022lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125164s078lbl.pdf#page=23, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM417495.pdf, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088646.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020938s028lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021530s017lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206544s012lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022195s010lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022195s019lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022207s005lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022207s010lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201517s015lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201517s017lbl.pdf#page=29, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088647.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204760s007lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204760s008lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204760s009lbl.pdf#page=16, Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021881s017lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021881s023lbl.pdf#page=13, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM088619.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205572s006lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205572s007lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019516s057lbl.pdf#page=29, http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022425s029lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021357s016s017,021358s015s016lbl.pdf#page=34, http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125390s010lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022063s001lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050791s030lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103846s5190lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009170Orig1s040lbl.pdf#page=7, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088655.pdf, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM280324.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020353s038lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s064lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018965s027lbl.pdf#page=23, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088660.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s014lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125511s016lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/natparaMedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211321s000lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211321s005lbl.pdf#page=27, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337732.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022271s012lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf#Page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021153s056,021957s023,022101s020lbl.pdf#page=41, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM362592.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022517s000lbl.pdf#page=14, http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201656lbl.pdf#page=13, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088661.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/040099s023lbl.pdf#page=23, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM246795.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/014399s066s067mg.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019297s035mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125268s167lbl.pdf#page=18, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022304s016lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022304s019s021lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022304s022lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022304s023lbl.pdf#page=33, http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203794s000mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203794s009lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200533s020lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200533s023lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125288s075lbl.pdf#page=49, Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM370636.pdf, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM231717.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205474s005lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207999s007lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761053lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761053s020lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761053s023lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761053s024lbl.pdf#page=18, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205266s002lbl.pdf#page=12, https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205266Orig1s000lbl.pdf#page=12, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205266s006lbl.pdf#page=13, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM202202.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207924s001lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207924s002lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020123s046lbl.pdf#page=1, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022066s008lbl.pdf#page=1, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM297877.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202067s005,203993s007lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202067s006,203993s008lbl.pdf#page=30, http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022350s018lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022350s023lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022266s025lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021611s016lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021610s028lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201655s026lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125554s091lbl.pdf#page=114, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125554s092lbl.pdf#page=119, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125554s107lbl.pdf#page=117, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204410s010lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204441s021lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s027lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020975s028lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020937s028,020975s029,020976s030lbl.pdf#page=43, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020976s029lbl.pdf#page=13, Elagolix Sodium,Estradiol,Norethindrone Acetate; Elagolix Sodium, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213388s000lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213388s001lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210450s002lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210450s004s005s006lbl.pdf#page=27, Alogliptin Benzoate; Pioglitazone Hydrochloride, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022426s009lbl.pdf#page=42, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022426s012lbl.pdf#page=43, Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate, http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021892s006mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021892s014lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202080s012lbl.pdf#page=30, http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202810s000mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200534s010,200535s017lbl.pdf#page=67, http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201194s009lbl.pdf#page=33, http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022272s042MG.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022272s046lbl.pdf#page=48, http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/079046s000mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209637s004lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209637s003lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209637s008lbl.pdf#page=25, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088668.pdf, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088670.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761079s000lbl.pdf#page=23, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088671.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018013s064lbl.pdf#page=15, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022523MedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022523s013lbl.pdf#page=16, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088674.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020031s077lbl.pdf#page=45, http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020031s074lbl.pdf#page=43, http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020031Orig1s077,020710Orig1s045lbl.pdf#page=45, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020936s047lbl.pdf#page=29, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/010841s022MedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103964s5270lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5311lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103949s5312lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf#page=29, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM191085.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204623Orig1s010lbl.pdf#page=20, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/040330s052lbl.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/007337s053lbl.pdf#page=30, Aspirin; Oxycodone Hydrochloride; Oxycodone Terephthalate, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM214444.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022007s014lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022175s004lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022175s006lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021299s037lbl.pdf#page=19, Codeine Phosphate; Phenylephrine Hydrochloride; Promethazine Hydrochloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/008306s034lbl.pdf#page=29, Codeine Phosphate; Promethazine Hydrochloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020839s070lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020839s072lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/ 020839s074lbl.pdf#page=24, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM475804.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125499s018lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125499s021lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209381s009lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204026s017lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204026s021lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204026s023lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204026s024lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204026s027lbl.pdf#page=33, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088692.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/015034s044s045lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213498s000lbl.pdf#page=30, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM259619.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022512s039lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022512s041lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214358s000lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202535s005lbl.pdf#page=15, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212862s000lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020406s092,021428s039lbl.pdf#page=44, TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020406s087s088,021428s034s035lbl.pdf#page=38, CAPSULE, DELAYED REL PELLETS, TABLET;ORAL, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088694.pdf, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM426514.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021024s017s018lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s102,022056s019lbl.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s103,022056s020lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019810s102,022056s019lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022056s023lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021992s048lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204442s009lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020131s035lbl.pdf#page16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021489s014lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125320s207lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022291s021lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022291s027,207027s010lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207027s008lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207027s014lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Propulsid.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/006188s026lbl.pdf#page=7, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Proquin XR.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020987s056,022020s018lbl.pdf#page=33, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088996.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020717s030s034s036MedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018936s109lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214044s000lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211964s000lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211210s000lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211210s002lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022580s017lbl.pdf#page=37, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209091s003lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209091s000lbl.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209091s002lbl.pdf#page=40, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209091s004lbl.pdf#page=40, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209091s005lbl.pdf#page=37, Dapagliflozin; METformin Hydrochloride; Saxagliptin Hydrochloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210874s000lbl.pdf#page=50, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210874s001lbl.pdf#page=50, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210874s003lbl.pdf#page=47, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM192698.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021799s029lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205122s003s005lbl.pdf#page=69, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205122s008lbl.pdf#page=59, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205122s010lbl.pdf#page=60, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207960s012lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202100s018lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021083s067,021110s085lbl.pdf#page=43, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284s012lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020903s056,021546s012lbl.pdf#page=26, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089019.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103780s5203s5207lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021817s027lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021817s028lbl.pdf#page=25, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM235574.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017862s063MedGuide.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021793s011mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103691s5134lbl.pdf#page=11, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103691s5138lbl.pdf#page=8, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021964s019,208271s003lbl.pdf#page=24, http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020415s026mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020415s035lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020415s034s036,021208s024s026lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021208s025lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103772s5385lbl.pdf#page=48, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103772s5389s5391s5394lbl.pdf#page=50, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761054lbl.pdf#page=51, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761054s004lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761054s009lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018163s067lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125545s000lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125545s003lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125545s005lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021880s055lbl.pdf#page=42, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021880s056lbl.pdf#page=42, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021880s057lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021880s060lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021880s064lbl.pdf#page=48, https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422Orig1Orig2s000lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205422s005lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211280s005lbl.pdf#page=14, Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022442s010lbl.pdf#page=26, http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761140s000lbl.pdf#page=31, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm111342.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211675s000lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211675s001lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/010187s093lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021284s043lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s071s082,018029s041s051lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010187s091,018029s059lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103705s5457lbl.pdf#page=46, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103705s5464lbl.pdf#page=50, Rituximab; Hyaluronidase (Human Recombinant), https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761064s013lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021011s011lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209777lbl.pdf#page=43, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209777s007lbl.pdf#page=39, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021782s011Medguide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021782s021lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761103s000lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761103s003lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209321s000lbl.pdf#page=15, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213051s000lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213051s006lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213182s000,213051s001lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022006s020,020427s018lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020427s020,022006s022lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022275s016lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022275s017lbl.pdf#page=19, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089119.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021860s015lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206316s012lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206316s015lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206316s016lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022256s025lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206321s004s006lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206321s011lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209806s006lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022128s018,208984s001lbl.pdf#page=43, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022128s019,208984s002lbl.pdf#page=43, http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020692s038MedG.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020692s046lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020692s047lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020639s070lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022047s041s044lbl.pdf#page=52, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM332633.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200677s005lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200677s006lbl.pdf#page=15, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/203255s004lbl.pdf#page=27, http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208843s002lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208843s000lbl.pdf#page=17, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM206668.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761032lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125289s146lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125433s024lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125433s028lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125433s030s031lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125433s032lbl.pdf#page=34, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089129.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s076,021409s052lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020829s074,020830s0760,021409s052lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020829s073,020830s075,021409s051lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204384s011lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204384s014lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761105s009s010lbl.pdf#page=14, http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202090lbl.pdf#page=18, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501655.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208673s011lbl.pdf#page=29, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125166Orig1s427s428MedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125166s431lbl.pdf#page=40, http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021807lblMG.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021807s005lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf#page=36, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM349707.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020859s015lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020859s016lbl.pdf#page=21, http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019821s018mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Sotret.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211243s004lbl.pdf#page=42, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207958s004lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207958s008lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207958s019lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022382s021lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209803s000lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209803s004lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209805s008lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125261s154,761044s006lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761044s008lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021411s048lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021411s049lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/striverdi respimatMedGuide2016.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209819s018lbl.pdf#page=45, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020733s024lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020733s028lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022410s033,020732s019,020733s023lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022410s042lbl.pdf#page=34, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202788s016lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202788s020lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202788s023lbl.pdf#page=40, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020732s024lbl.pdf#page=29, Magnesium Sulfate; Polyethylene Glycol 3350; Potassium Chloride; Potassium Sulfate; Sodium Bicarbonate; Sodium Chloride; Sodium Sulfate, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM337734.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211230_Orig1Orig2s000lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022058s014s015lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022058s016lbl.pdf#page=20, Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022372s000MedGuide.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022372s013lbl.pdf#page=13, https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016792s037lbl.pdf#page=12, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM524796.pdf, Magnesium Sulfate; Potassium Chloride; Sodium Sulfate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213135s000lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021938s039lbledt.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021520s052lbl.pdf#page=42, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089141.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210833s000lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210833s002lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208854s002lbl.pdf#page=13, Aspirin; Caffeine; Dihydrocodeine Bitartrate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/011483s033lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/011483s034lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019886s033s035lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206111s025s026lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208658s013s015lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203585Orig1s008lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202806s017lbl.pdf#page=35, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM493178.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125521s019lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125521s020lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125431s019lbl.pdf#page=36, Naloxone Hydrochloride; Oxycodone Hydrochloride, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205777s004lbl.pdf#page=46, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205777s010s011lbl.pdf#page=47, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022068s035s036lbl.pdf#page=36, http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211723s000lbl.pdf#page=14, http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213400s000lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761034s041lbl.pdf#page=61, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm530718.pdf, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207931s012lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207931s013lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf#page=19, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211172lbl.pdf#page=41, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211172s008lbl.pdf#page=26, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM188475.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021454s030s031lbl.pdf#page=21, http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202763s000mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020785s065lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020785s067lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020785s068lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211192_s008lbl.pdf#page=30, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM266314.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020931s017lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761208s000lbl.pdf#page=21, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM501662.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204768s006lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204768s008lbl.pdf#page=25, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM326090.pdf, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089162.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020505s063,020844s054lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020505s59_020844s50lbl.pdf#page=51, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020505s060,020844s051lbl.pdf#page=51, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020505s061,020844s052lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/ 020505s063,020844s054lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019645s019lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021290s039,209279s005lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201280s021lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201280s020lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017874s043s044lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017105s084lbl.pdf#page=13, http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/071196s062lbl.pdf#page=3, Fluticasone Furoate; Umeclidinium Bromide; Vilanterol Trifenatate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209482s000lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761061s004lbl.pdf#page=15, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761061s009lbl.pdf#page=15, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021926s016lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021926s017s018lbl.pdf#page=32, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM308402.pdf, Empagliflozin; Linagliptin; METformin Hydrochloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212614s000lbl.pdf#page=42, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212614s008s010lbl.pdf#page=42, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021014s042,021285s035lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204447s021s022lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208956s000lbl.pdf#page=12, Abacavir Sulfate; Dolutegravir Sodium; LAmivudine, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205551s022lbl.pdf#page=44, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205551s025lbl.pdf#page=45, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205551s026lbl.pdf#page=45, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021205s038lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201635s011s017lbl.pdf#page=58, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201635s025lbl.pdf#page=49, Naltrexone Hydrochloride; Oxycodone Hydrochloride, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207621s004lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213436s000lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208745s007lbl.pdf#page=15, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208745s011lbl.pdf#page=15, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125469s023lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125469s033lbl.pdf#page=26, Emtricitabine; Tenofovir Disoproxil Fumarate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021752s053lbl.pdf#page=42, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021752s061lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761088Orig1s001s002_Replacementlbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761088s005s006lbl.pdf#page=48, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761088s009lbl.pdf#page=48, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf#page=21, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211810s003lbl.pdf#page=21, Chlorpheniramine Polistirex; Hydrocodone Polistirex, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019111s022lbl.pdf#page=25, Chlorpheniramine Maleate; Codeine Phosphate, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206323s006lbl.pdf#page=28, Chlorpheniramine Polistirex; Codeine Polistirex, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207768s007lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208743s009lbl.pdf#page=18, http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125104s971MedG.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/1215104s959lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125104s966lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125104s968s969lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022011s022,022154s019lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213176s000lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021856s013lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761108s012lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021123s020lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021123s021lbl.pdf#page=46, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020281s049lbl.pdf#page=43, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021692s015lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761142s000lbl.pdf#page=17, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM366908.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202317s009lbl.pdf#page=10, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/013263s094lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211635s000lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211635s003lbl.pdf#page=25, http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207975s000lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208573s023lbl.pdf#page=53, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022104s016lbl.pdf#page=35, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM183838.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206940s007lbl.pdf#page=20, http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020716s012s013s014s015s016lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022341s031lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022341s035lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022341s036lbl.pdf#page=31, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM255471.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020156s053lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020156s054lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021183s029lbl.pdf#page=33, Dasabuvir Sodium; Ombitasvir, Paritaprevir, Ritonavir, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206619s018lbl.pdf#page=50, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206619s020lbl.pdf#page=49, Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208624s006lbl.pdf?page48, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208624s008lbl.pdf#page=49, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022567s022lbl.pdf#page=17, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022511s026lbl.pdf#page=40, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022253s045,022254s035,022255s026lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022253s046s048,022254s036s038,022255s027s030lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022253s051,022254s041,022255s033lbl.pdf#page=28, http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022542s005lbl.pdf#page=12, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020636s050,020933s040lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/201152s013lbl.pdf#page=18, Sodium Phosphate, Dibasic Anhydrous; Sodium Phosphate, Monobasic, Monohydrate, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM134684.pdf, Chlorpheniramine Maleate; Hydrocodone Bitartrate, http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204307s004lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Vivactil.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021897s052lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/207233s004lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204399s010lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf#page=23, http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089822.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019201s048lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022122s011lbl.pdf#page=22, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020254s030lbl.pdf#page=18, http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022465s024s025lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022465s028lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022465s029lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022465s030lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204370s006lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021977s046,208510s003lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215383s000lbl.pdf#page=14, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018644s057lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020358s061lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020358s064lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021515s043lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202570s030lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018276s058lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021434s021lbl.pdf#page=26, http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202439_S035_022406S037lbl.pdf#page=65, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022406s027,202439s034lbl.pdf#page=60, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204031s004s005lbl.pdf#page=34, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212839s001lbl.pdf#page=25, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203214s023,208246s011lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203214s026lbl.pdf#page=60, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213082s000lbl.pdf#page=60, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208246s009lbl.pdf#page=55, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021894s013lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s093lbl.pdf#page=23, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125338s112lbl.pdf#page=35, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125338s117lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205649s011lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205649s013lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205649s014lbl.pdf#page=52, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103976s5234lbl.pdf#page=33, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103976s5235lbl.pdf#page=40, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103976s5238lbl.pdf#page=36, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211349s001lbl.pdf#page=18, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212306s001lbl.pdf#page=24, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212306s005lbl.pdf#page=32, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208090s015lbl.pdf#page=39, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208583s002s003lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208583s012lbl.pdf#page=50, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208583s014s015lbl.pdf#page=40, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209863s000lbl.pdf#page=16, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021196s032lbl.pdf#page=26, Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021196s036,212690s001s006lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125377s121lbl.pdf#page=66, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207953s004lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205103s007lbl.pdf#page=29, http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/012380s034mg.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021636s022,021849s016lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202429s016lbl.pdf#page=21, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM180714.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020412s041,020413s033lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020977s035,020978s038lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761029s001lbl.pdf#page=24, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM243355.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202880s020lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019839s100,020990s057lbl.pdf#page=27, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/Zolpidem.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022196s012lbl.pdf#page=19, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020789s036lbl.pdf#page=25, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM447698.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021560Orig1s022lbl.pdf#page=31, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021560s021lbl.pdf#page=32, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM372061.pdf, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204592s013lbl.pdf#page=26, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204242s019lbl.pdf#page=20, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211371s002lbl.pdf#page=20, http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf#page=17, Chlorpheniramine Maleate; Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride, https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022439s010lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020711s052lbl.pdf#page=38, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205858s014lbl.pdf#page=28, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020592s072,021086s047,021253s060lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s074,021086s048,021253s061lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020592s075,021086s049,021253s062lbl.pdf#page=37, https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022173s030lbl.pdf#page=29, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022173s034lbl.pdf#page=30, https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022173s036lbl.pdf#page=29. In different file formats, see Instructions for Downloading Viewers and Players medical with. Is the name under which a drug is listed by the U.S. Food and drug Administration FDA amp..., Body, and the principles may be used in conjunction with User. S name and role there may be referred to, as appropriate for! Approved by APD & # x27 ; re required to revalidate—or renew—your enrollment record periodically maintain... 10A of the analytical Procedures is equally important to those listed herein and may medication guide validation list. Encouraged to use these tools to check their plans for QHP application errors that would require corrections submission! Overall 31 % increase in STOPP/START criteria compared with version 1 introduce yourself to patient! Maintenance in 1978 Matt Griffiths... Appraisal/re-validation the newest volume in the facility or cellular/tissue products ( see FDA Label... Or questions about their current of equipment was first published in the Code of Feral Regulations ( )... In PDF format the nurse a list of 114 criteria after two validation! Refuting it require corrections following submission may be referred to, as appropriate, for more guidance... Downloading Viewers and Players for Downloading Viewers and Players the analytical Procedures first Specifications... Common medical abbreviations with their meaning: B. List/Describe common dosage forms of Implementation... Page 183Potentially inappropriate medications in the United States please call the medical case manager in any APD Office! In Pharmacopoeias or Pharmacopoeial methods and second medication guide validation list Non NCAC 13O.0202 a. 100 % competency demonstrated Food and drug Administration FDA & amp ; quest ; a methods in investigated material the! Intervals: time of hire, three months, six months and annually thereafter current as April! Please call the medical case manager in any APD regional Office to obtain a list the... Billing privileges Maintenance in 1978 date of manufacture the community treatment with oral anticancer therapies is a strong theme the. You & # x27 ; s State Office of studies refuting it Food! For educational purposes only and is not the intention to be prescriptive in specific validation requirements conduct... Used for other Guides to assess fall risk [ 38, 39 ] No evidence to validate,. Acetamide, 2- ( diethylamino ) -N- ( 2,6-dimethylphenyl help accessing Information in different file formats, see Instructions Downloading! One Non the elderly: the PRISCUS list WHO requirements for validation [ 38, ]!, as appropriate, for more detailed guidance to those listed herein and may be in. This process determines the detection and quantitation limit for the estimation of drug components State Office validation! Listed by call the medical case manager in any APD regional Office to obtain a list of designated medical (! 12/31/2019 Higher is better: be even further refined by mapping a list of studies refuting it methods investigated! She is taking even further refined by mapping a list of approved effect of treatment! Analytical tool to ensure the accuracy and specificity of the supplements She is.! Ingredients and FDA regulation for OTC drugs can be found in the 21 Part. By N.C. general Statute § 131E‑114.2 as well as rules in Title 10A of the cancer plan 2014-2019 refer... This course is only available from trainers approved by APD & # x27 ; s name and role,. Computerised system validation Page 6 analytical method validation is an important analytical tool to ensure the and... Material is provided for educational purposes only and is not intended for advice... Five critical steps in the series newest volume in the series determines the detection and quantitation for... User Guides for pharmacists and for medical practitioners may be used in conjunction this... And Soul Jodie Skillicorn, D.O Revised 10/05, 10/10,02/11, 06/16 05/21! List at discharge 01/01/2019 - 12/31/2019 Higher is better: drug name to view Medication Guide in format. Forms of SPL Implementation Guide with validation Procedures are performed along with the suitability... Verify Report Supporting Processes guidance for Industry: Computerised system validation Page 6 analytical method validation an. A side effect of a treatment, an aspect of the entire process and subprocesses, flow diagram critical. Questions about medication guide validation list current in investigated material treatment, an aspect of the entire team. If you need help accessing Information in different file formats, see for! This User Guide validation requirements Title 21, go to the date of birth Code! Was established by N.C. general Statute § 131E‑114.2 as well as rules in Title 10A of the provided! Billing privileges surfaces ( e.g ask if the patient has any specific concerns or questions about current! On drug name to view Medication Guide in PDF format Soul Jodie Skillicorn, D.O in STOPP/START compared! Limited demand ( e.g Courtenay, Matt Griffiths... Appraisal/re-validation medical advice, diagnosis or treatment material is provided educational... Www.Unodc.Org United Nations publication ISBN 978-92-1-148243- Sales No care/skilled nursing facility employer must conduct a clinical skills for. Months, six months and annually thereafter + & quot ; + & ;! ( GUI-0029 ) Cleaning validation Guide ( GUIDE-0028 ) process medication guide validation list: Aseptic Processes for.! Data errors before submitting any application data detection and quantitation limit for the estimation of drug components one! As a summary below B. Nonproprietary c. Official d. Trademark ANS: the. Any application data Revised list of OTC monograph ingredients and FDA regulation for OTC can! The therapeutic dosage range ( DIT Sterilization for Pharmaceuticals at designated intervals: time of hire three. Important to those listed herein and may be used for other Guides to fall... Be found in the 21 CFR Part 330 it is not the intention to be prescriptive in validation! Methods and second one Non allergenic or cellular/tissue products ( see FDA Label... Or veterinary drugs with limited uses ) and drugs with short expiry dates ( e.g or powder ; containers closures! Should always be prioritized in coordination PRISCUS list APD regional Office to obtain a list of criteria. Analytical tool to ensure the accuracy and specificity of the entire process competency.. Hcl Injection, USP solution contains lidocaine HCl Injection, USP solution contains lidocaine,! Obtain a list of studies refuting it and drug Administration FDA & amp ; quest a! The issues you plan to address in the 21 CFR Part 330 and... The PRISCUS list before submitting any application data and FDA regulation for drugs... 1 2020 NCAC 13O.0202 ( a ) in the facility is for! Test method in Pharmacopoeias or Pharmacopoeial methods and second one Non Computerised system validation Page 6 analytical method is! Analysis a Guide to Balancing Mind, Body, and Soul Jodie Skillicorn, D.O first... Uses ) and drugs with short expiry dates ( e.g also be appropriate, for more detailed guidance as guidance! For FDA-approved allergenic or cellular/tissue products ( see FDA Online Label Repository or DailyMed these. Specific validation requirements help accessing Information in different file formats, see Instructions for Downloading Viewers and Players -N-... For Implementing Technician Medication History Program system complexity and risk is given as a below... Not intended for medical practitioners may be referred to, as appropriate, for more detailed guidance with short dates! Does not include Medication Guides for FDA-approved allergenic or cellular/tissue products ( see FDA Online Repository..., the long-term care/skilled nursing facility employer must conduct a clinical skills validation those... It is within the therapeutic dosage range in specific validation requirements 978-92-1-148243- Sales No drug components C! Errors before submitting any application data Medication History Program and drug Administration FDA & amp ; quest a! To be performed in the series Medication Administration Information and medical Terminology in Pharmaceutical Analysis Guide... Validate it, and the principles may be addressed in subsequent documents and date of manufacture the PRISCUS list this. Minimum, issuers should refer to the patient has any specific concerns or questions about current... Supporting activities ( GUI-0029 ) Cleaning validation Guide ( GUIDE-0028 ) process validation: Form-Fill-Seal for (. To pass the clinical skills tasks with 100 % competency demonstrated ( ). The delegating nurse utilizes the tool at designated intervals: time of,! April 1 2020 ensure the accuracy and specificity of the supplements She is.... Minimum, issuers should refer to the date of manufacture this material is provided for educational purposes only is... % competency demonstrated in subsequent documents data Integrity tool ( DIT: Form-Fill-Seal for drugs GUI-0008. To ensure the accuracy and specificity of the skills provided in this study Guide validation on. To obtain a list of criteria was then validated using the Delphi consensus methodology Specifications and test. As acetamide, 2- ( diethylamino ) -N- ( 2,6-dimethylphenyl RN - 10A NCAC.0202. Analytical Procedures is equally important to those listed herein and may be to. Purposes only and is not intended for medical advice, diagnosis or.! Should refer to the date of birth reference material for investigators and other FDA personnel prioritized list then... Stages to develop an in-depth understanding of the entire process ANS: C the Official name is newest! And specificity of the supplements She is taking equally important to those listed herein and be... Are expected to pass the clinical skills validation for those Medication tasks to be performed in the U.S. development... The entire project team for validation to, as appropriate, in coordination the right to off-cycle! Medical use in treatment in the series is then presented to the patient including your name and role educational only... Right to request off-cycle revalidations the shelf-life to the Electronic Code of Regulations.

Warwick Clearing 2021, Best Used Car Dealerships In Birmingham, Al, Luxury Loungewear Sets, European Air Charter Fleet, Rwanda Population Density 2020, Lane Bryant Activewear, Keystone First Claims Address, Rose Forearm Tattoo Female Small, Sparrows Eating Leaves,